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ABSTRACT 
 
The thesis entitled “Design and Synthesis of Bile Acid Based Conjugates, Dimers, 
Oligomers and Their Pharmacological and Supramolecular Applications” has been 
divided into three chapters. 
Chapter 1: Synthesis of bile acid based dimers, oligomers to study their micelle like 
properties and studies towards the synthesis of cholaphanes. 
Chapter 2: Synthesis of bile acid-fluconazole conjugates, new fluconazole analogues 
using click reaction, bile acid based amino alcohols and their bioevaluation. 
Chapter 3: Stereoselective synthesis of steroidal side chain from 16-
dehydropregnalone acetate. 
 
 
Chapter 1:  Synthesis of bile acid based dimers, oligomers to study their micelle like    
properties and studies towards the synthesis of cholaphanes. 
 
Introduction 
 
Bile acids are versatile building blocks for the design and synthesis of macrocyclic and 
open chain supramolecular hosts due to their large, rigid, and curved steroidal skeletons, 
chemically different hydroxy groups, enantiomeric purities, and their unique 
amphiphilicity, together with their availability and low cost.1 Bile acids and their 
derivatives are also important compounds from the pharmaceutical point of view. In their 
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dimeric form, bile acids or their derivatives show inclusion of methanol, carbohydrate, 
perylene, and DNA. Such dimers also act as artificial ionophores and are found to be 
potential receptors for neutral molecules or metal cations.2 The configuration of dendritic 
structures based on steroidal moieties may give rise to potential molecular assemblies 
with many interesting nano-scale applications, including organ-targeted drug carriers, 
artificial ion channels, organogelators and molecular switches.  
In this chapter we present our studies on the synthesis of bile acid dimers and oligomers 
based on Cu (I) catalyzed 1,3 dipolar cycloaddition of terminal alkyne and azide (click 
reaction).3 Their micelle like properties have been studied by encapsulation of hydrophilic 
dye (cresol red) in non polar solvent (chloroform) using solid liquid extraction protocol 
and efforts towards the synthesis of cholaphanes. 
Synthesis of terminal alkynes:  
Terminal alkynes were synthesized by esterification  of bile acids 1 and 2 using an excess 
of propargyl alcohol and a catalytic amount of p-TSA (para-toluenesulfonic acid) to get 
compounds 3  and 4  (Scheme 1). 
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Scheme 1: Reagents and Conditions: p-TSA (10 mol %), Propargyl alcohol, 55-60 οC, 7 h, 3 
(96%), 4 (95%). 
 
Synthesis of azides:  
Azides at C-3 and C-24 positions of bile acids were synthesized (Scheme 2). 
Esterification of deoxycholic acid 1 and cholic acid 2 using excess methanol and catalytic 
amount of p-TSA afforded methyl esters 5 and 6. These esters on reduction with LAH 
followed by selective mesylation and nucleophilic substitution of mesyl with sodium 
azide gave C-24 azido compounds 7 and 8. C-3α-azides 9 and 10 were synthesized using 
Mitsunobu reaction, while C-3β-azides 11 and 12 were synthesized by mesylation 
followed by nucleophilic substitution of mesyl with sodium azide from compounds 5 and 
6. 
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Scheme 2: Reagents and conditions: (a) p-TSA/MeOH, 25 ºC, 24 h, 95-96%; (b) LAH/THF, 
25 ºC, 2 h, 93-97%; (c) MsCl, Et3N, CH2Cl2, 0 ºC, 10 min; (d) NaN3, DMF, 60 ºC, 
3 h, 93-94%.; (e) Ph3P, Et3N, MeSO3H, DEAD, THF, 45 οC, 24 h.; 75-78 % 
(overall in 2 steps). 
 
Syntheis of Dimers:  
Bile acid dimers 13-18 (Figure 1) linked with 1,2,3 triazole were synthesized on 1,3-
dipolar cycloaddition of terminal alkynes 3 or 4 (Scheme 1) with terminal azides 7-12 
(Scheme 2). General graphical representation is depicted in Scheme 3. In our earlier 
report4 this reaction was carried out in t-BuOH/H2O using catalytic amount CuSO4·5H2O 
and sodium ascorbate at 60-65 °C for 3-12 h. Same reaction under microwave irradiation 
in DMF/H2O was completed in less  reaction time (5-10 min). 
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Figure 1: Bile acid dimers 
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Scheme 3: Reagents and conditions: CuSO4·5H2O (5 mol %), Sodium ascorbate (40 mol %), 
DMF:H2O (4:1), Microwave, 5 min,  90-96%. 
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Synthesis of oligomers:  
Hydroxyl groups of bile acids were esterified using chloroacetyl chloride (Scheme 4). 
Transformation of chloro functionality of compound 19 and 20 into azides 21 and 22 was 
carried out using sodium azide in DMF at 75 ºC. These two azides on cycloaddition 
reaction with propargyl ester 3 and 4 afforded trimer 23 and tetramer 24 respectively.5 
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Scheme 4: Reagents and conditions: (a) CaH2, ClCH2COCl, TBAB, toluene (reflux), 3 h, 78-
86%; (b) NaN3, DMF, 75 ºC, 12 h, 79-82%; (c) CuSO4·5H2O (5 mol %), Sodium 
ascorbate (40 mol%), DMF:H2O (4:1), Microwave, 5 min, 23 (85%), 24 (82%). 
 
Dye solubilisation study:  
Bile acid dendrons can adopt a reverse micelle-like conformation in nonpolar solvent with 
the hydrophobic face turned outwards (towards the solvent).6 In this chapter, the study of 
micellar properties of newly synthesized dimers 13-18 and oligomers 23 and 24 was 
carried out by solid liquid extraction protocol of the sodium salt of cresol red dye 
(hydrophilic dye) in nonpolar solvent, chloroform. We found that dimeric and oligomeric 
compounds of methyl cholate as well as methyl deoxycholate show linear increase in dye 
solubilisation with increasing concentrations of the dimer, trimer and tetramer (Figure 2). 
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     A          B 
Figure 2: Solubilisation of cresol red (CR) in chloroform tetramer 24, C-24 dimer 14, trimer 
23, and monomers 5, 6. Straight lines (A) are linear fit lines of experimental data; 
Cresol red sodium salt solubilisation in chloroform having a ratio of chloroform: 
cresol red: oligomer (1 mL : 5 mg : 5 mg)  each sample was stirred for 12 h and 
filtered through 0.5 µ PTFE membrane. vial 1 has no additive, vial 2 has C-24 
dimer 14,  vial 3 has trimer 23 and vial 4  has tetramer 24 (B). 
 
 
Synthesis of cholaphanes: 
The design of novel macrocyclic synthetic receptors with molecular cavities is one of the 
most important fields in supramolecular chemistry. There host molecules can serves as 
model compounds for more complex biological systems and are important for molecular 
recognition of substrates in enzymatic processes. Typical macrocycles bind substrates in 
their defined cavity. The steroid nucleus can make unique contributions to this area owing 
to its size, chirality, and rigid polycyclic framework. The bile acids, such as cholic acid or 
deoxycholic acid, have proved especially useful, because of their availability and useful 
levels of functionalization. On one hand, the presence of functionality at both ends of 
these units suggests the construction of macrocyclic structures which may possess a high 
level of inward-directed polar functionality. On the other, the codirected hydroxyl groups 
present in most bile acids may be exploited (directly or indirectly) in podand-type 
receptors, linear dimeric hosts, or “facial amphiphiles”.7 Here, we tried to synthesize 
cholaphanes using click chemistry approach. Starting from propargyl ester of deoxycholic 
acid 3, we synthesized compounds 25, 28 and 30 which contain both azide and acetylene 
groups in the same molecule (Scheme 5). 1,3-Dipolar cycloaddition of 25 under various 
conditions failed to give cholaphane 26. This reaction led to uncharacterized solid 
material. In the next attempt, we increased the chain length at C-3 position. 
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Scheme 5: Reagents and conditions: (a) MsCl, Et3N, CH2Cl2 0 οC, 10 min.; (b) NaN3, DMF, 
60-65 οC, 3 h, 90%; (c) CuSO4·5H2O (5 mol%), Sodium ascorbate (40 mol%), 
DMF:H2O (4:1), Microwave, 5 min. (d) Jones reagent, acetone, 5 min, 96%. (e) 
Trimethyl sulphoxoniumiodide, NaH, DMSO-THF, rt. 2 h, 91%; f) Propargyl 
bromide, Zn, DMF/THF 25 οC, 5 h. 
 
Under cycloaddition reaction conditions these bifunctional compounds 28 and 30 again 
led to uncharacterized solid material instead of cholaphanes 29 and 31. Efforts to 
synthesize cholaphane by changing the positions of alkyne and azide group as in 30 
remained unsuccessful. 
 
Chapter 2: Synthesis of bile acid-fluconazole conjugate, new fluconazole analogues 
using click reaction, bile acid based amino alcohols and their bioevaluation. 
Section I: Synthesis of bile acid-fluconazole conjugates and new fluconazole 
analogues using click reaction and their bioevaluation.  
Introduction 
The incidence of life threatening fungal infections has tremendously increased in last two 
decades due to greater use of immunosuppressive drugs, prolonged use of broad-spectrum 
Abstract 
 xii
antibiotics, wide-spread use of indwelling catheters and also in cancer and AIDS patients. 
The presently marketed antifungal drugs are either highly toxic (amphotericin-B) or are 
becoming ineffective due to appearance of resistant strains (flucytosine and azoles). 
Azole antifungals (Figure 3) are strong inhibitors of lanosterol 14α-demethylase, which is 
major component of fungal cell membrane.8  
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Figure 3: Azole based antifungal drugs. 
 
Fluconazole is an orally effective, potent and safe triazole based antifungal drug, 
with favorable pharmacokinetic characteristics and low toxicity. Due to the emergence of 
new fungal pathogens, development of resistance to fluconazole, great efforts have been 
made to modify the chemical structure of fluconazole, in order to broaden its antifungal 
activity and increase its potency.9  
Bile acid transporters have been shown to accept and carry a variety of drugs that 
are attached at different positions of bile acids. A common feature of bile acid derived 
antimicrobials is its potential to exhibit facially amphiphilic nature due to polar hydroxyl 
groups on one face and nonpolar hydrophobic methyl groups on the other face. Polyene 
macrolide amphotericin B, peptide antimicrobial agent polymixin B and squalamine in 
the cyclic form show such amphiphilicity and function as ionophores.10  
Herein we designed bile acid- fluconazole conjugates (Scheme 6) in which one of 
the 1,2,4 triazole ring of fluconazole has been modified as substituted 1,2,3 triazole ring 
using click reaction.11 In our approach to synthesize these new molecules 35-38 (Scheme 
6) we considered performing click reaction to connect fluconazole part containing 
terminal alkyne 34 and bile acid containing azides 7, 8, 11, and 12 (Scheme 2). 
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Accordingly, we synthesized 2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-yn-
2-ol 34 by propargylation of the corresponding ketone 33 by using propargyl bromide and 
zinc dust to obtain racemic compound 34 (Scheme 6). 
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Scheme 6: Reagents and conditions: (a) AlCl3, 1,2-dichloroethane, chloroacetyl chloride, 25 ºC, 
7 h; (b) 1,2,4-triazole, NaHCO3, toluene, reflux, 4 h, (overall 55% in two steps); (c) 
Zn, Propargyl bromide, DMF/THF, 25 ºC, 5 h, 95%; (d) CuSO4·5H2O (5 mol%), 
Sodium ascorbate (40 mol%), DMF:H2O (9:1), Microwave, 5 min,  90-95%. 
 
Under microwave irradiation, compound 34 was reacted with C-24 azide 7 (Scheme 2) in 
DMF/H2O using catalytic amount of Cu(I) to give fluconazole-bile acid conjugate 35 as a 
diasteriomeric mixture in 92% yield. We then extrapolated the ligation protocol 
successfully to other bile acid derived azides 8, 11 and 12 (Scheme 2) and synthesized 
fluconazole-bile acid conjugates 36, 37 and 38.  
The rationale for this drug design approach was based on the expectation that in 
these conjugates bile acid part would be useful to permeabilize the fungal cell membrane 
as well as transporter of the pharmacophore of fluconazole because of its amphiphilic 
nature and hence the conjugates were predicted to be more active than fluconazole itself. 
But all these fluconazole bile acid bioconjugates showed moderate antifungal activity 
against Candida species (MIC ranging from 3.12 to 6.25 µg/mL). 
In order to find out the role of bile acid, we then synthesized two compounds 23 
and 24 in which fluconazole part was attached with ester linkage. Accordingly, oxirane 
39 was synthesized from the corresponding ketone 33 (Scheme 7). Opening of oxirane 39 
with sodium azide gave racemic azido alcohol 40. Microwave assisted copper catalyzed 
1,3-dipolar cycloaddition of the azido alcohol 40 with propargyl esters 3 and 4 (Scheme 
1), afforded diastereomeric mixture of compounds 41 and 42 in high yields. Compounds 
41 and 42 showed much better antifungal activity against Candida species than 
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compounds 35-38. We thought that ester functionality in these molecules may be 
hydrolyzing at physiological pH and the compounds having 1,4-substituted 1,2,3-triazole 
may be more active. 
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Scheme7: Reagents and conditions: (a) Trimethylsulfoxonium iodide, NaH, DMSO-THF, rt, 2 
h, 91%; (b) NaN3, DMF, 60-65 οC, 12 h, 75%; (c) CuSO4·5H2O (5 mol %), Sodium 
ascorbate (40 mol %), DMF:H2O (4:1), Microwave 10 min. 
 
Encouraged by these biological results we synthesized fluconazole analogues 
containing monosubstituted (43, 45) and 1,4-disubstituted (44, 46 and 47) 1,2,3-triazoles 
from two common intermediates 34 and 40 as described in (Scheme 8) and studied their 
biological activity. 
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Scheme 8: Reagents and conditions: (a) CuSO4·5H2O (5 mol%), Sodium ascorbate (40 mol%), 
DMF:H2O (4:1), Microwave (245 W), 10 min; (b) CuSO4·5H2O (5 mol%), Sodium 
ascorbate (40 mol%), DMF:H2O (4:1), Microwave (175 W), 10 min. 
 
All these newly synthesized compounds were found to show good antifungal 
activity. From the biological data, it was observed that compounds 43 and 45 having 
monosubstituted 1,2,3-triazole ring which are isosteres of fluconazole and compound 46 
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containing trimethylsilyl group, showed good in vitro antifungal activity  against fungal 
pathogens C. albicans, C. neoformans and S. schenckii, which was comparable with 
fluconazole but these compounds were less active than amphotericin B and ketoconazole. 
1,4-disubstituted 1,2,3-triazole compounds 44 and 47 with long alkyl chains showed very 
good antifungal activity against all the tested fungal pathogens. Compound 44 showed 
much better activity for C. albicans (IC50 0.001 µg/mL), C. neopharmans (IC50 <0.006 
µg/mL) and C. parapsilosis (IC50 0.002 µg/mL) as compared with fluconazole, 
amphotericin B and ketoconazole, while compound 47 was found to be less active than 
compound 44 but showed better activity against C. albicans (IC50 0.018 µg/mL), C. 
neopharmans (IC50 <0.01 µg/mL) and C. parapsilosis (IC50 0.043 µg/mL) as compared 
with fluconazole and amphotericin B. Hence the lead compounds 44 and 47 were tested 
for in vivo activity against C. albicans intravenous challenge in Swiss mice.  
Antiproliiferative activities of these molecules were tested against human heptocellular 
carcinoma Hep 3B and human epithelial carcinoma A431 cell lines.  
 
Section II: Synthesis and bioevaluation of bile acid based amino alcohols. 
Introduction 
The medicinal chemistry of steroids covers a large and interesting series of structures and 
biological activities.12 Although the number of steroidal natural products is limited, 
millions of hybrids steroid conjugates can be prepared. This new approach seems to be 
very promising in the development of lead molecule. The sterol-polyamine conjugates as 
a new class of antibiotics have attracted much interest in recent years. Squalamine is the 
first sterol-polyamine conjugate having broad spectrum antimicrobial activity. Due to the 
low availability of squalamine from natural resources, several groups are working on the 
synthesis of squalamine and its analogs (Figure 4).  
NHN
H
HO
O
NH
HHO
O
OH
H2N N
H H
OH
O
OH
N
H
OSO3H
H OH
NH
NH2
HN
H2N
NHN
H
HO3SO
O
H2N
N
H H
OH
NH
NH2
OSO3H
H2N
Squqlamine
 
Figure 4: Sterol-polyamine conjugates. 
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Some of the analoges show better activity than squalamine.13  
Variations in the structure of the analogues led to changes in the spectrum of 
activity against variety of bacteria and yeasts. From the literature studies it is observed that 
three common elements are required for their characteristic activity (i) long and rigid 
hydrophobic unit; (ii) a flexible hydrophilic chain which is linked to hydrophobic unit; (iii) 
a pendant polar head group. The precise structure of the polyamine is not important. The 
sulfate groups can be replaced by a carboxylate or hydroxyl or even removed altogether. 
The structure of the rigid hydrophobic unit i.e. steroid can also be varied. 
In our approach we synthesized new steroidal amino alcohol having short linker at 
C-3 position of bile acids. For this synthesis C-3 oxiranes 50 and 51 were the key 
intermediates. These oxiranes were prepared from methyl esters 5 and 6 of bile acids 
(Scheme 2) by oxidation followed and regioselective epoxidation using 
dimethyloxosulfonium methylide to obtain oxiranes 50 and 51 (Scheme 9). Stereochemistry 
at C-3 was assigned by 1H-NMR studies of oxiranes 50, 51, 54, 55 and confirmed by single 
crystal X-ray of compound 58. 
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Scheme 9: Reagents and conditions: (a) CrO3, H2SO4, acetone, 0-10 °C,10 min; (b) Trimethyl 
sulphoxoniumiodide, NaH, DMSO-THF, rt. 2 h; (c) Ac2O, DMAP, Et3N, CH2Cl2, 
25-28 °C, 24 h; (d) K2CO3, MeOH, 3 h; e) Ag2CO3, toluene, reflux, 5 h. 
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Opening of oxiranes 58 and 59 with sodium azide (Scheme 10) gave azido 
alcohols which on further hydrogenation on Pd-C gave amino alcohols 62 and 63. Ethylene 
diamine derivatives 66 and 67 were synthesized by opening of oxiranes with N1-(Boc)-1,2- 
diaminoethane followed by deprotection. These new molecules containing amino alcohols 
with a small linker at C-3 are under biological evaluation. 
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Scheme 10: Reagents and conditions: (a) NaN3, DMF, 60-65 οC, 12 h; (b) H2 / Pd-C, MeOH; 
(c) N1-(Boc)-1,2-diaminoethane, MeOH reflux 2 h; (d) 50% TFA/CH2Cl2. 
 
Chapter 3: Stereoselective synthesis of steroidal side chain from 16-
dehydropregnalone acetate  
Introduction 
Steroid is a large class of natural products and widely distributed in animals and plants. A 
wide variety of steroids are known having modified side chains and is attached to the 
tetracyclic rigid unit at C-17 with both natural C-20(R) and unnatural C-20(S) 
stereochemistry.14 The introduction of steroid side chain onto tetracyclic steroidal starting 
material to yield product with the natural C-20(R) configuration has been the subject of 
investigation by several research groups.15 There are several reports for the stereoselective 
side chain synthesis at C-20 using ene reaction, catalytic hydrogenation, deoxygenation, 
Wittig rearrangement, aldol condensation, Michel addition, sigmatropic rearrangement and 
also using organometalic reagents such as organocopper, organoborane, organopalladium, 
organozirconium, organoruthenium reagent. In this chapter we report a short stereoeslective 
synthesis of cholanic acid derivative starting from commercially available C-20 oxo steroid 
16-dehydropregnelone acetate (16-DPA) 68 (Scheme 11). Palladium catalyzed carbon-
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carbon bond forming Heck reaction between C-20 vinyl iodide 70 with methyl acrylate to 
form unsaturated compound 71 and transfer hydrogenation with triethylsilane and Pd/C are 
the key steps for stereoselective side chain synthesis. 
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Scheme 11: Reagent and condition: (a)10% Pd/C, H2, EtOAc, 45 psi, 25-30 ºC, 12 h, 98%; 
(b) Hydazine hydrate, NEt3, MeOH, 25-30 ºC; (c) I2, NEt3, THF,  25-30 ºC; (d) 
Pd(OAc)2 (0.04%), K2CO3, methyl acrylate, DMF, 25-30 ºC, 12 h; (e) 10-20% 
Pd-C (by weight), MeOH, triethylsilane (excess), 10-20 min. 
 
Chemoselective catalytic hydrogenation of compound 68 with 10% Pd-C in ethyl acetate 
followed by reaction with hydrazine hydrate afforded C-20 hydrazone 69. Oxidation of 
hydrazone 69 with iodine in the presence of organic base gave vinyl iodide 70 in good 
yield. Heck coupling of vinyl iodide 70 with methyl acrylate, afforded unsaturated carbonyl 
compound 71. There are some reports for the reduction of C-20(21) or C-20(22) double 
bond by using different catalysts such as PtO2, (Ph3P)3 RhCl with less selectivity at C-20.  
Pd-Carbon induced catalytic transfer hydrogenation with triethylsilane of compound 71 
afforded compounds 72 and 73 as an epimeric mixture at C-20. Hydrogenation of this 
mixture using H2/Pd-C in ethylacetate gave a mixture of compounds 74 and 75 in 8:2 ratio. 
On crystallization in methanol:dichloromethane (9:1) gave pure cholanic acid derivative 74. 
The stereochemistry of compound 74 at C-20(R) was confirmed by single crystal X-ray. 
Cholanic acid is a key intermediate for the synthesis of large number of biologically active 
steroids having natural C-20(R) configuration. 
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